If an experiment is repeated under similar conditions, the results should be the same. In reality, the situation is often ...

The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.

A phase 2 trial evaluated peanut OIT in adults with peanut-allergic using real-world peanut products, employing a Simon’s minimax two-stage design with stop:go futility analysis. Participants ...

The dating “rulebook” tells us men chase younger women while women seek older, more established partners… but is this ...

For combination therapy, the FDA recommends 200 mg of penpulimab-kcqx every 3 weeks. Monotherapy is recommended at 200 mg ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

Risky driving by parents and other motorists who do the school run is putting children in danger, according to a study published in the journal Traffic Injury Prevention. Double parking ...

Myasthenia Gravis Foundation of America (MGFA) Class II-IV gMG and likely not in need v of a respirator for the duration of the study, as judged by the Investigator. * The confirmation of the ...

Johnson & Johnson announced results from additional analyses of the Phase 3 Vivacity-MG3 double-blind study and the ongoing open-label extensiona, evaluating the long-term efficacy and safety of ...

Charities Regulator takes action after information provided a year ago and engagement with Vision Ireland Stock image A leading charity for blind people is being investigated by a watchdog.

In two phase 3, double-blind, double-dummy, event-driven trials (GEMINI 1 and GEMINI 2), participants with relapsing multiple sclerosis were randomly assigned in a 1:1 ratio to receive ...